Steven Cohen’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.5K Buy
+21,260
New +$64.5K ﹤0.01% 3732
2026
Q1
– Sell
-314,180
Closed -$864K – 3831
2025
Q4
$864K Buy
314,180
+269,947
+610% +$770K ﹤0.01% 2948
2025
Q3
$152K Sell
44,233
-15,788
-26% -$57.6K ﹤0.01% 2172
2025
Q2
$206K Buy
+60,021
New +$158K ﹤0.01% 1978
2025
Q1
– Sell
-54,893
Closed -$175K – 2085
2024
Q4
$175K Buy
+54,893
New +$448K ﹤0.01% 1915
2024
Q3
– Sell
-202,572
Closed -$2.02M – 2006
2024
Q2
$2.02M Sell
202,572
-1,142,754
-85% -$16.5M 0.01% 1092
2024
Q1
$16M Buy
+1,345,326
New +$11.5M 0.04% 537

Other funds holding CATX

Steven Cohen's CATX Position: Q3 2026 in Review

Steven Cohen opened a new position in Perspective Therapeutics (CATX) in Q3 2026: 21,260 shares worth $58.5K. The stake represents ﹤0.01% of the portfolio and ranks #3732 among its holdings. This is a return to the name: Steven Cohen previously reported a position in CATX as recently as Q4 2025.

Steven Cohen first reported a position in CATX in Q1 2024 and has held it in 7 quarters since. The position peaked at $16M in Q1 2024. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • Steven Cohen held 21,260 shares of Perspective Therapeutics worth $58.5K as of Q3 2026.
  • Perspective Therapeutics was a new Steven Cohen position in Q3 2026.
  • Perspective Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3732 holding.
  • Steven Cohen first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Steven Cohen's Perspective Therapeutics position peaked at $16M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.